痛风与年龄相关性黄斑变性风险
这项回顾性队列研究利用多中心医疗研究网络,比较痛风并处方降尿酸药患者与倾向评分匹配的无痛风对照者,发现痛风患者5年内发生干性AMD、晚期干性AMD、湿性AMD及需抗VEGF治疗的风险均升高,结论认为需进一步研究高尿酸血症的机制与影响。
要点
- 痛风患者5年内发生干性AMD的风险相对风险为2.73(95%CI 2.30-3.25,P<0.001)。
- 痛风患者需后续抗血管内皮生长因子治疗的相对风险为2.80(95%CI 2.14-3.67,P<0.001)。
- 早期AMD合并痛风者与早期AMD无痛风者相比观察到相似趋势。
核心结论
- 在national多中心数据库中,痛风患者相较对照者发生AMD及进展至晚期阶段的风险升高。
- 作者认为需进一步研究高尿酸血症的机制与影响以阐明这些关联。
研究设计与样本
- 回顾性队列研究,使用多中心医疗研究网络识别国际疾病分类第10版特发性痛风且处方降尿酸药的患者(痛风队列)。
- 与匹配的无痛风诊断患者队列(对照队列)比较眼科结局,并采用倾向评分匹配平衡基线人口学与健康状况。
主要发现
- 5年时痛风患者发生干性AMD的相对风险为2.73(95%CI 2.30-3.25,P<0.001)。
- 5年时痛风患者发生晚期干性AMD的相对风险为2.64(95%CI 1.32-5.28,P<0.001)。
- 5年时痛风患者发生湿性AMD的相对风险为2.48(95%CI 1.82-3.38,P<0.001)。
- 5年时痛风患者需后续抗血管内皮生长因子治疗的相对风险为2.80(95%CI 2.14-3.67,P<0.001)。
- 早期AMD合并痛风者与早期AMD无痛风者相比观察到相似趋势。
局限性
- 作者认为需进一步研究高尿酸血症的机制与影响以阐明这些关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the association between gout and subsequent development and progression of age-related macular degeneration (AMD). METHODS: In this retrospective cohort study, a multicenter health care research network was used to identify patients with an International Classification of Diseases, 10th Revision for idiopathic gout and a prescription for uric acid-lowering agent (Gout cohort) compared with a matched cohort of patients without a diagnosis of gout (Control cohort) for ophthalmic outcomes. Propensity score matching was applied to balance baseline demographics and health status between cohorts. RESULTS: Patients with gout had an increased risk of developing dry AMD (relative risk, 2.73, 95% confidence intervals, 2.30-3.25; P < 0.001), advanced dry AMD (relative risk, 2.64, 95% confidence intervals, 1.32-5.28; P < 0.001), wet AMD (relative risk, 2.48, 95% confidence intervals, 1.82-3.38; P < 0.001), and needing subsequent antivascular endothelial growth factor therapy (relative risk, 2.80, 95% confidence intervals, 2.14-3.67; P < 0.001) compared with those without gout at 5 years. Similar trends were observed among patients with early AMD and gout compared with those with early AMD without gout. CONCLUSION: In a national multicenter database, an increased risk of AMD development and progression to advanced disease stages was found among patient with gout compared with controls. Additional investigation into the mechanisms and effects of hyperuricemia are necessary to clarify these associations.
引用
- Alshaikhsalama AM, Alsoudi AF, Wai KM, et al. GOUT AND RISK OF AGE-RELATED MACULAR DEGENERATION. Retina. 2025. PMID: 40632946. doi:10.1097/IAE.0000000000004604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。